An integrated digital media and global distribution platform for transformative, emerging-growth companies. https://xitter.cf/t.co/WNSpAhc2DI
New York, NY
Joined June 2009
- Tweets19.3K
- Following1.5K
- Followers8.5K
- Likes104
.@skyxplatforms $SKYX and Its Subsidiary Deako Announce They Expect to Supply 60,000 Units of Their Smart Home Technologies to over 700 Homes to Prominent Oklahoma & Texas Home Builder, Home Creations in The Next 12 Months, as the Company Continues to Grow Its Market Penetration
globenewswire.com/news-relea…
.@skyxplatforms $SKYX and Its Subsidiary Deako Announce They Will Supply Over 80,000 Units of Their Smart Home Technologies to Over 1,000 Homes of Prominent Home Builder Maronda Homes, as the Company Continues to Grow Its Market Penetration
globenewswire.com/news-relea…
.@AmpliTech Group Receives Record $21.7 Million Purchase Order
Largest Single Purchase Order in Company History Brings Cumulative Program Orders to $34 Million; Total company Backlog Now Exceeds Record $51 Million
globenewswire.com/news-relea…
.@aclarioninc $ACON Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
globenewswire.com/news-relea…
.@AtlasClearATCH $ATCH Expands Correspondent Clearing Business with Seventh Broker-Dealer Agreement
globenewswire.com/news-relea…
.@QuoinPharma $QNRX Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
investors.quoinpharma.com/ne…
.@skyxplatforms $SKYX Announces Closing of Merger with Leading AI Smart Home Technology Company Deako, Positioning the Combined Company to Become a Leader in the AI Smart Home Market
globenewswire.com/news-relea…
.@QuoinPharma $QNRX Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
investors.quoinpharma.com/ne…
.@sonotekcorp $SOTK Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems
globenewswire.com/news-relea…
.@sbcmedical_hd $SBC to Present at Cantor Fitzgerald Hong Kong’s Inaugural Asia Longevity Forum
globenewswire.com/news-relea…
Sono-Tek $SOTK Announces Fiscal Second Quarter and First Half 2027 Earnings Conference Call
Conference Call on Wednesday, October 14, 2026 at 10:30 am ET
globenewswire.com/news-relea…
.@AuddiaInc $AUUD Cancels October 7th Shareholder Meeting to Align Merger Vote with Expanding AI Infrastructure Opportunity
globenewswire.com/news-relea…
.@aclarioninc Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
$ACON
globenewswire.com/news-relea…
.@skyxplatforms Signs Agreement to Supply Its Safe-Advanced & Smart Technologies to Trump Towers Landmark Luxury Development in Hyderabad, India, One of India’s Leading Tech Hubs
$SKYX
globenewswire.com/news-relea…
.@sonotekcorp $SOTK Announces Record $7.19 Million in Orders from Advanced Clean Energy Sector Customer
globenewswire.com/news-relea…
.@sbcmedical_hd $SBC to Participate in Several Upcoming Investor Conferences in October 2026
globenewswire.com/news-relea…
Thank you to Crowdfund Insider for featuring my perspective on why SPACs have become the microcap IPO.
The traditional IPO market has moved up-market, and listing standards have tightened. For a lot of good companies, a SPAC is now the most viable path to the public markets. That makes the real question not whether SPACs are legitimate, but whether the people running these deals bring the discipline that taking a small company public requires.
Closing is not the finish line. It is where the company starts proving that the valuation, the plan and the story can survive public-market scrutiny. lnkd.in/gj62ZqF9
